Company / Income Tax
10x Genomics, Inc. Income Tax History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$3.6M
FY2025
5-year range
$3.6M / $6.3M
FY2021-FY2025
Trend
-26.2%
vs FY2024
Sector context
#106 of 156
Health Care
What the data says
At $4M, 10x Genomics, Inc.'s income tax ranks #51 of 156 in the Health Care sector. Income Tax has fluctuated over the past 9 years, ranging from $21,000 in FY2017 to $8M in FY2020.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of -15.1%.
Improved from $6M to $4M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -3.4%
- 5-Year CAGR
- -15.1%
- 10-Year CAGR
- -
Sector benchmark
#51 of 156 in Health CareTop 32% of 156This company $3.6M Sector average $142.5M
▼
-97.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -15.1%, indicating a declining trend.
- In FY2025, income tax decreased 26.2% year-over-year.
- Ranks #106 out of 156 companies in the Health Care sector.
- Peak income tax was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.6M | -26.2% |
| FY2024 | $4.9M | -22.2% |
| FY2023 | $6.3M | +57.3% |
| FY2022 | $4.0M | -10.6% |
| FY2021 | $4.5M | -45.4% |
| FY2020 | $8.3M | +3686.7% |
| FY2019 | $218.0K | +150.6% |
| FY2018 | $87.0K | +314.3% |
| FY2017 | $21.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026